Biodegradable polymers in drug delivery and oral vaccination

P Jana, M Shyam, S Singh, V Jayaprakash… - European Polymer …, 2021 - Elsevier
Over the years biodegradable polymers have emerged as promising polymeric materials in
drug delivery and vaccination due to their fascinating properties like biocompatibility …

Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses

MO Oyewumi, A Kumar, Z Cui - Expert review of vaccines, 2010 - Taylor & Francis
The development of novel immune adjuvants is emerging as a significant area of vaccine
delivery based on the continued necessity to amplify immune responses to a wide array of …

Chitosan and its derivatives in mucosal drug and vaccine delivery

IM Van der Lubben, JC Verhoef, G Borchard… - European Journal of …, 2001 - Elsevier
Numerous studies have demonstrated that chitosan and their derivatives (N-trimethyl
chitosan, mono-N-carboxymethyl chitosan) are effective and safe absorption enhancers to …

Chitosan for mucosal vaccination

IM Van der Lubben, JC Verhoef, G Borchard… - Advanced drug delivery …, 2001 - Elsevier
The striking advantage of mucosal vaccination is the production of local antibodies at the
sites where pathogens enter the body. Because vaccines alone are not sufficiently taken up …

Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres

I Gutierro, RM Hernandez, M Igartua, AR Gascon… - Vaccine, 2002 - Elsevier
BSA was entrapped in particles of different sizes (200, 500 and 1000nm) prepared from poly
(d, l-lactic-co-glycolic) acid by a double emulsion method. The particles were given, either …

Nanoparticle delivery systems in cancer vaccines

Y Krishnamachari, SM Geary, CD Lemke… - Pharmaceutical …, 2011 - Springer
Therapeutic strategies that involve the manipulation of the host's immune system are gaining
momentum in cancer research. Antigen-loaded nanocarriers are capable of being actively …

Exploiting PLGA-based biocompatible nanoparticles for next-generation tolerogenic vaccines against autoimmune disease

G Cappellano, C Comi, A Chiocchetti… - International Journal of …, 2019 - mdpi.com
Tolerogenic vaccines are aimed at inhibiting antigen-specific immune responses. Antigen-
loaded nanoparticles (NPs) have been recently emerged as ideal tools for tolerogenic …

Micro and nanoparticle‐based delivery systems for vaccine immunotherapy: an immunological and materials perspective

J Leleux, K Roy - Advanced healthcare materials, 2013 - Wiley Online Library
The development and widespread application of vaccines has been one of the most
significant achievements of modern medicine. Vaccines have not only been instrumental in …

Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies

S Wang, H Liu, X Zhang, F Qian - Protein & cell, 2015 - academic.oup.com
Most pathogens initiate their infections at the human mucosal surface. Therefore, mucosal
vaccination, especially through oral or intranasal administration routes, is highly desired for …

Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice

IM van der Lubben, G Kersten, MM Fretz, C Beuvery… - Vaccine, 2003 - Elsevier
In this study, the ability of chitosan microparticles to enhance both the systemic and local
immune responses against diphtheria toxoid (DT) after oral and nasal administration in mice …